Anticancer agent 58

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

Anticancer agent 58 

Anticancer agent 58 (compound 16) 对多种癌细胞具有抑制活性，特别是在 A549 和 T24 细胞中，IC50 分别为 0.6 μM 和 0.7 μM。Anticancer agent 58 通过激活 caspase 3/8/9 活性诱导细胞凋亡 (apoptosis)，也诱导 Ca2+ 和 ROS 水平升高。Anticancer agent 58 在 T24 异种移植小鼠模型中能显著抑制肿瘤生长。

Anticancer agent 58

Anticancer agent 58 Chemical Structure

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

Anticancer agent 58 (compound 16) has inhibitory activity against kinds of cancer cell lines, especially in A549 and T24 with IC50s of 0.6 μM and 0.7 μM, respectively. Anticancer agent 58 induces apoptosis by activating caspase 3/8/9 activity, and induces an increase of Ca2+ and ROS in cancer cells. Anticancer agent 58 significantly decreases mitochondrial membrane potential. Anticancer agent 58 can suppress tumor growth in T24 mouse xenograft model[1].

IC50 & Target

IC50: 0.6 μM in A549, 0.7 μM T24[1]
分子量

617.86

Formula

C39H55NO5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Yin Y, et al. Synthesis and in vitro/in vivo anticancer evaluation of pentacyclic triterpenoid derivatives linked with l-phenylalanine or l-proline [published online ahead of print, 2022 May 11]. Bioorg Chem. 2022;126:105865.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务